TB Research

Improving Treatment Adherence in Youths With Multidrug-Resistant Tuberculosis With Psychosocial Intervention

Dhumal G, Nevrekar N, Gupte N, Shrisunder R, Kulkarni P, Sarpotdar S, Pm A, Hosmani A, et al. (11 authors)

Brain and behavior · 2025-08

Abstract

Introduction Multidrug-resistant tuberculosis (MDR-TB) deeply impacts the well-being of adolescents and young adults (AYA), resulting in poor treatment adherence. Identifying psychosocial challenges and preferred interventions is essential to enhance treatment adherence and outcomes in this unique group. Methods This was a mixed-method study where participants aged between 15 and 24 years, diagnosed with MDR-TB, were recruited for in-depth interviews and a semi-structured questionnaire. Results The individual-level psychosocial challenges included mental stress, suicidal ideation, reluctance to continue medication, perceived and experienced stigma, and socio-economic burdens. Health system-related challenges encompassed delayed diagnosis, drug stockouts, and negative experiences with Health Care Providers (HCPs). Among 75 participants, the median age was 20.5 years, with 57% (n = 41) females, 85% (n = 62) single, and a median treatment duration of 8 months at the interview. Seventy-two percent (n = 54) of the participants reported psychological issues such as irritation, loneliness, anxiety, sleep disorder, suicidal ideation, and stigma. Individual-level interventions were preferred by 61% (n = 46) of participants, including social media, deep breathing, and exercise training. Conclusions To enhance results in MDR-TB, it is crucial to develop and assess personalized psychosocial interventions with tailored adjustments to tackle the psychosocial obstacles encountered by adolescents and young adults with MDR-TB.

MeSH terms

  • Humans
  • Tuberculosis, Multidrug-Resistant
  • Adolescent
  • Adult
  • Female
  • Male
  • Medication Adherence
  • Young Adult
  • Social Stigma
  • Suicidal Ideation
  • Psychosocial Intervention